Axler, Toronto, ON. Canada /ID# 223740

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Crohn's disease

Running trials

• Active, not recruiting

  Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

  NCT04524611· Phase 3· AbbVie· Source